Copyright Reports & Markets. All rights reserved.

Global Ischemia Reperfusion Injury Market Growth (Status and Outlook) 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Ischemia Reperfusion Injury Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Ischemia Reperfusion Injury Market Size 2014-2024
        • 2.1.2 Ischemia Reperfusion Injury Market Size CAGR by Region
      • 2.2 Ischemia Reperfusion Injury Segment by Type
        • 2.2.1 Phase 1
        • 2.2.2 Phase 2
        • 2.2.3 Preclinical
      • 2.3 Ischemia Reperfusion Injury Market Size by Type
        • 2.3.1 Global Ischemia Reperfusion Injury Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Ischemia Reperfusion Injury Market Size Growth Rate by Type (2014-2019)
      • 2.4 Ischemia Reperfusion Injury Segment by Application
        • 2.4.1 Heart Injury
        • 2.4.2 Kidney Injury
        • 2.4.3 Intestine Injury
        • 2.4.4 Other Injury
      • 2.5 Ischemia Reperfusion Injury Market Size by Application
        • 2.5.1 Global Ischemia Reperfusion Injury Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Ischemia Reperfusion Injury Market Size Growth Rate by Application (2014-2019)

      3 Global Ischemia Reperfusion Injury by Players

      • 3.1 Global Ischemia Reperfusion Injury Market Size Market Share by Players
        • 3.1.1 Global Ischemia Reperfusion Injury Market Size by Players (2017-2019)
        • 3.1.2 Global Ischemia Reperfusion Injury Market Size Market Share by Players (2017-2019)
      • 3.2 Global Ischemia Reperfusion Injury Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Ischemia Reperfusion Injury by Regions

      • 4.1 Ischemia Reperfusion Injury Market Size by Regions
      • 4.2 Americas Ischemia Reperfusion Injury Market Size Growth
      • 4.3 APAC Ischemia Reperfusion Injury Market Size Growth
      • 4.4 Europe Ischemia Reperfusion Injury Market Size Growth
      • 4.5 Middle East & Africa Ischemia Reperfusion Injury Market Size Growth

      5 Americas

      • 5.1 Americas Ischemia Reperfusion Injury Market Size by Countries
      • 5.2 Americas Ischemia Reperfusion Injury Market Size by Type
      • 5.3 Americas Ischemia Reperfusion Injury Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Ischemia Reperfusion Injury Market Size by Countries
      • 6.2 APAC Ischemia Reperfusion Injury Market Size by Type
      • 6.3 APAC Ischemia Reperfusion Injury Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Ischemia Reperfusion Injury by Countries
      • 7.2 Europe Ischemia Reperfusion Injury Market Size by Type
      • 7.3 Europe Ischemia Reperfusion Injury Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Ischemia Reperfusion Injury by Countries
      • 8.2 Middle East & Africa Ischemia Reperfusion Injury Market Size by Type
      • 8.3 Middle East & Africa Ischemia Reperfusion Injury Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Ischemia Reperfusion Injury Market Forecast

      • 10.1 Global Ischemia Reperfusion Injury Market Size Forecast (2019-2024)
      • 10.2 Global Ischemia Reperfusion Injury Forecast by Regions
        • 10.2.1 Global Ischemia Reperfusion Injury Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Ischemia Reperfusion Injury Forecast by Type
      • 10.8 Global Ischemia Reperfusion Injury Forecast by Application

      11 Key Players Analysis

      • 11.1 Angion Biomedica
        • 11.1.1 Company Details
        • 11.1.2 Ischemia Reperfusion Injury Product Offered
        • 11.1.3 Angion Biomedica Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Angion Biomedica News
      • 11.2 Catalyst Biosciences
        • 11.2.1 Company Details
        • 11.2.2 Ischemia Reperfusion Injury Product Offered
        • 11.2.3 Catalyst Biosciences Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Catalyst Biosciences News
      • 11.3 Ischemix Inc
        • 11.3.1 Company Details
        • 11.3.2 Ischemia Reperfusion Injury Product Offered
        • 11.3.3 Ischemix Inc Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Ischemix Inc News
      • 11.4 Opsona Therapeutics
        • 11.4.1 Company Details
        • 11.4.2 Ischemia Reperfusion Injury Product Offered
        • 11.4.3 Opsona Therapeutics Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Opsona Therapeutics News
      • 11.5 Pharming
        • 11.5.1 Company Details
        • 11.5.2 Ischemia Reperfusion Injury Product Offered
        • 11.5.3 Pharming Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Pharming News
      • 11.6 TheraSource
        • 11.6.1 Company Details
        • 11.6.2 Ischemia Reperfusion Injury Product Offered
        • 11.6.3 TheraSource Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 TheraSource News
      • 11.7 Bolder Biotechnology
        • 11.7.1 Company Details
        • 11.7.2 Ischemia Reperfusion Injury Product Offered
        • 11.7.3 Bolder Biotechnology Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Bolder Biotechnology News
      • 11.8 Corline Biomedical
        • 11.8.1 Company Details
        • 11.8.2 Ischemia Reperfusion Injury Product Offered
        • 11.8.3 Corline Biomedical Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 Corline Biomedical News
      • 11.9 Mifcortx
        • 11.9.1 Company Details
        • 11.9.2 Ischemia Reperfusion Injury Product Offered
        • 11.9.3 Mifcortx Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 Mifcortx News
      • 11.10 Balmes Transplantation
        • 11.10.1 Company Details
        • 11.10.2 Ischemia Reperfusion Injury Product Offered
        • 11.10.3 Balmes Transplantation Ischemia Reperfusion Injury Revenue, Gross Margin and Market Share (2017-2019)
        • 11.10.4 Main Business Overview
        • 11.10.5 Balmes Transplantation News
      • 11.11 NovelMed Therapeutics
      • 11.12 Hope Pharmaceuticals
      • 11.13 Omeros Corp
      • 11.14 Prothix
      • 11.15 SBI Pharmaceuticals

      12 Research Findings and Conclusion

      Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.
      Ischemic reperfusion injury is the tissue damage that happens when blood supply returns to the tissue after a period of lack of oxygen. The absence of oxygen and nutrients creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative. Symptoms include headache, bradycardia, seizures and hypertension. Risk factors include hypertension, hyperlipidemia, diabetes, insulin resistance, heart failure, altered coronary circulation, and aging.
      Ischemia Reperfusion Injury can be applied in Heart Injury, Kidney Injury, Intestine Injury and Other. The most of Ischemia Reperfusion Injury is used in Kidney Injury, and the market share of that is about 66% in 2035.
      North America is the largest sales place, with a sales market share nearly 54% in 2035. Following North America, Europe is the second largest sales place with the Sales market share of 14.5%. Ischemia Reperfusion Injury market in Asia Pacific region is expected to exhibit the highest growth rate especially in the developing Asian countries like China & India.

      According to this study, over the next five years the Ischemia Reperfusion Injury market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Ischemia Reperfusion Injury business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares and growth opportunities of Ischemia Reperfusion Injury market by product type, application, key companies and key regions.

      This study considers the Ischemia Reperfusion Injury value generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
      Phase 1
      Phase 2
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
      Heart Injury
      Kidney Injury
      Intestine Injury
      Other Injury

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Angion Biomedica
      Catalyst Biosciences
      Ischemix Inc
      Opsona Therapeutics
      Pharming
      TheraSource
      Bolder Biotechnology
      Corline Biomedical
      Mifcortx
      Balmes Transplantation
      NovelMed Therapeutics
      Hope Pharmaceuticals
      Omeros Corp
      Prothix
      SBI Pharmaceuticals

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Ischemia Reperfusion Injury market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Ischemia Reperfusion Injury market by identifying its various subsegments.
      Focuses on the key global Ischemia Reperfusion Injury players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Ischemia Reperfusion Injury with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the size of Ischemia Reperfusion Injury submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now